Recent

% | $
Quotes you view appear here for quick access.

Prima Biomed Ltd. Message Board

  • trendstok trendstok Oct 19, 2012 12:14 AM Flag

    Ord Minnett Research about Prima BioMed Limited

    Prima BioMed (PRR) has released interim data from the CAN-003 trial (a 63 patient Phase IIb study) ahead of a meeting of the International Gynaecologic Cancer Society in Vancouver, Canada. The key data points can be grouped into three categories:
    - Safety
    - Efficacy
    - Biological Activity

 
PBMD
1.040.00(0.00%)May 27 4:00 PMEDT